Annexon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Annexon and other ETFs, options, and stocks.About ANNX
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington’s and alzheimer’s disease, multiple sclerosis, glaucoma, parkinson’s disease, and spinal muscular atrophy.
CEODouglas Love
CEODouglas Love
Employees100
Employees100
HeadquartersBrisbane, California
HeadquartersBrisbane, California
Founded2011
Founded2011
Employees100
Employees100
ANNX Key Statistics
Market cap649.11M
Market cap649.11M
Price-Earnings ratio-3.19
Price-Earnings ratio-3.19
Dividend yield—
Dividend yield—
Average volume3.45M
Average volume3.45M
High today$4.58
High today$4.58
Low today$4.25
Low today$4.25
Open price$4.44
Open price$4.44
Volume2.49M
Volume2.49M
52 Week high$5.66
52 Week high$5.66
52 Week low$1.29
52 Week low$1.29
Stock Snapshot
With a market cap of 649.11M, Annexon(ANNX) trades at $4.50. The stock has a price-to-earnings ratio of -3.19.
On 2025-12-04, Annexon(ANNX) stock moved within a range of $4.25 to $4.58. With shares now at $4.50, the stock is trading +5.9% above its intraday low and -1.7% below the session's peak.
Trading volume for Annexon(ANNX) stock has reached 2.49M, versus its average volume of 3.45M.
Over the past 52 weeks, Annexon(ANNX) stock has traded between a high of $5.66 and a low of $1.29.
Over the past 52 weeks, Annexon(ANNX) stock has traded between a high of $5.66 and a low of $1.29.
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ANNX. This list is generated using Robinhood data, and it’s not a recommendation.